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ABSTRACT 
Neuropeptide oxytocin is implicated in complex emotional and social behavior and it appears to 
play an important role in learning and memory. Animal studies have shown that the effects of 
exogenous oxytocin on memory vary according to the timing of administration, context, gender and 
dose and it may improve the memory of social, but not non-social stimuli. Oxytocin is intricately 
involved in a broad array of neuropsychiatric functions and may therefore be a pharmacological 
target for several psychiatric disorders. This review summarizes the potential effects of oxytocin on 
long-term memory processes in healthy humans. The effects of intranasal oxytocin on human 
memory is controversial and the studies included in this review have applied a variety of learning 
paradigms, in turn, producing variable outcomes. Specifically, data on the long-term memory of 
non-emotional stimuli found no effect or even worsening in memory, while studies using emotional 
stimuli showed an improvement of long-term memory performance. In conclusion, this review 
identified a link between long-term memory performance and exogenous intranasal oxytocin in 
humans, although these results still warrant further confirmation in large, multicenter randomized 
controlled trials. 
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 INTRODUCTION 
Long-term memory refers to the ability to encode, store, retain and subsequently recall 
information and past experiences [Gabrieli 1998]. In particular, recognition of and discrimination 
between conspecifics are essential behavioral components in the repertoire of memory for social 
stimuli in animals such as mammals, to enable appropriate social interactions. Findings from animal 
and human studies point unequivocally to the involvement of oxytocin in the development and 
maintenance of attachment and affiliative behavior [Lim and Young 2006]. Beside its essential role 
for mammalian parturition and lactation, oxytocin is implicated in complex emotional and social 
behavior and appears to play a role in both learning and memory [Gulpinar and Yegen 2004; 
Heinrichs et al. 2004]. Memory impairment is a particularly relevant issue for pharmacological 
research, since it may be associated with many psychiatric and neurological disorders [Hill et al. 
2013; Koen and Yonelinas 2014; Petersen et al. 2014; Rock et al. 2014]. 
Oxytocin is a neuropeptide mainly synthesized in the brain’s hypothalamic para-ventricular 
and supra-optic nuclei by magnocellular neurons, which is processed along the axonal projections to 
the posterior lobe of the pituitary [Ludwig and Leng 2006]. This neuropeptide can act on different 
brain areas as a neuromodulator, playing a role in several neurophysiological processes and 
behavior [Stoop 2012], such as feeding, anxiety, aggression, social recognition and stress response 
[Hashimoto et al. 2012]. Oxytocin is intricately involved in a broad array of neuropsychiatric 
functions and may be a common factor playing a vital role in multiple psychiatric disorders such as 
autism, schizophrenia, mood and anxiety disorders [Cochran et al. 2013]. 
Recently, the interest around oxytocin has grown, and this neuropeptide has been claimed to 
be a potential pharmacological target for the treatment of behavioral and cognitive symptoms in 
mental disorders [Chini et al. 2014; Gumley et al. 2014; Meyer-Lindenberg et al. 2011; Okamoto et 
al. 2016]. Central oxytocin receptors have been found in various brain regions crucial for 
information processing and memory, including hippocampus, striatum, amygdala, hypothalamus, 
nucleus accumbens and midbrain [Gimpl and Fahrenholz 2001]. Animal studies showed that 
exogenous oxytocin may have both promnestic and amnestic effects depending on timing of 
delivery, context, gender and dose [Bielsky and Young 2004; Chini et al. 2014]. In particular, the 
amnestic proprieties of oxytocin may have an important role in the context of specific reproductive 
conditions [Heinrichs et al. 2004].  
Whereas the effects of oxytocin on memory have been thoroughly investigated in animals, 
research on humans is relatively limited. Studies reporting temporary verbal episodic memory 
impairment in women during pregnancy and post-partum [Brett and Baxendale 2001] concluded 
that oxytocin may have an important biological function by inhibiting acquisition of aversive 
experiences during labor [Heinrichs et al. 2004]. Inferences from the effects of oxytocin cannot, 
however, be drawn based exclusively on correlational data of endogenous physiological 
concentrations. More direct evidence can be obtained examining exogenous administration of 
oxytocin and its consequences on behavior and cognition. A recent review on studies in healthy 
participants administered oxytocin using a nasal spray, reported  a variety of behavioral and 
cognitive effects in social decision making and in processing social stimuli [Macdonald and 
Macdonald 2010]. 
Despite data showing that intranasal administration of oxytocin could increase cerebrospinal 
fluid levels of the neuropeptide in humans [Striepens et al. 2013], the bio-availability of exogenous 
intranasal oxytocin in the brain remains an open question, and more work is needed to clarify this 
key point [Leng and Ludwig 2016; Valstad et al. 2016]. This review provides a detailed summary of 
the evidence of the effects of exogenous intranasal oxytocin on long-term memory in healthy 
human adults.  
METHODS 
Inclusion/exclusion criteria 
We included; (1) original research studies, (2) conducted on healthy adults participants, (3) with the 
administration of intranasal oxytocin (single or repeated dose), which (4) provided at least one 
outcome of long-term memory and (5) were published between January 1980 and June 2016. We 
decided to select exclusively studies in which participants received  oxytocin intranasally, since this 
is the most common method for oxytocin administration in human studies. Furthermore, articles 
published in languages other than English, as well as animal studies, reports of secondary data such 
as meta-analyses, reviews or letters were also excluded.  
 
Search strategy and selection of the studies 
The electronic database Medline (PubMed) was investigated for records which either 
contained the items “Oxytocin” in the title and “memory”, “retrieval”, “encoding” or “recognition” 
in the title or abstract. Only English-language articles and studies on human subjects were selected 
with a  date range restricted to 1980-2016 (see Figure 1, Table 1 and Table 2). Abstracts were 
reviewed and all relevant original research articles were considered in detail, including a review of 
references from each publication to identify additional sources. References and “cited by” 
information of identified articles were further scanned, but no additional studies were found. 
Articles were then chosen by two independent reviewers based on the relevance and aim of the 
review, study design, quality of study and overall manuscript quality.  
To focus on the impact of oxytocin on long-term memory and emotional processing, as 
reported in previous studies [Guastella and MacLeod 2012; Macdonald and Macdonald 2010], we 
identified two main categories of research: a) studies on the effect of oxytocin on long-term 
memory of non-emotional stimuli (e.g., non-emotional words, non-emotional objects, non-
emotional neutral faces) and b), studies on the effect of oxytocin on the long-term memory of 
emotional stimuli (e.g., emotional words, emotional faces, emotional pictures). 
 
RESULTS 
In total, 18 articles published between 1980 and 2016 fitted the criteria and were included in the 
systematic review (see Figure 1). A total of 939 participants were enrolled in the selected studies 
(87% males, 13% females). 
 
Impact of oxytocin on long-term memory performance using non-emotional stimuli  
The first studies that examined the effects of exogenous intranasal oxytocin on human long-
term memory used non-emotional stimuli (i.e., words or neutral faces) (see Table 1). In the first 
study, two different long-term memory tests were administered during and after the assumption of 
oxytocin: a paired-associate word task, which required the subject to learn and recall 10 word-pairs 
and a neutral face picture matching task [Ferrier et al. 1980]. The authors found that the ability to 
recall word pairs decreased after learning, and markedly so in later recall, while no effects were 
detected for the picture matching task. Subsequently, Fehm-Wolfsdorf et al. [1984] demonstrated 
that oxytocin administered during the memory retrieval phase, but not before the encoding phase, 
decreased memory performance [Fehm-Wolfsdorf et al. 1988]. Bruins et al. [1992] reported that 
oxytocin administered before learning a word-list, reduced initial storage (i.e., correctly 
remembered words after the initial presentation) and the rate of storage (i.e., number of trials to 
recall words at least once) for verbal material in healthy young men, but no difference was detected 
for delayed recall.  
Furthermore, Heinrichs et al. [2004] showed that in a long-term memory test, oxytocin 
significantly impaired recall performance compared with placebo treatment, irrespective of the 
meaning of the words used. Herzmann et al. [2012] directly contrasted the effects of oxytocin on the 
recognition of non-emotional stimuli (neutral faces and houses), showing a moderate memory 
impairment for both type of stimuli. In the study by Blandòn-Gitlin et al. [2014], participants 
received intranasal solutions of oxytocin or placebo before encoding viewing white and black 
neutral faces or during recognition. Only if oxytocin was administered before encoding, did it 
increase black neutral faces recognition, eliminating own-race bias. Finally, Bate et al. [2015] 
reported that participants’ overall memory performance was not affected by oxytocin, but it elicited 
a positive response bias, i.e., participants were more likely to make false-positive recognition errors. 
In summary, studies on intranasal oxytocin effects on long-term memory for non-emotional 
stimuli either found a reduction of performance or no effects, with the exception of a single study 
that showed that performance improved, revealing a reduction of own-race memory bias during a 
face recognition task [Blandon-Gitlin et al. 2014]. 
 
Impact of oxytocin on long-term memory performance using  emotional  stimuli  
More recent research has examined the impact of oxytocin on long-term memory 
performance using emotional stimuli such as faces with emotional expressions, emotional pictures 
and emotional words (see Table 2). Guastella et al. [2008] explored the effect of oxytocin 
administered before the encoding phase on memory of faces displaying neutral and emotional 
expressions (happiness or anger). During an incidental recognition test, they found oxytocin 
enhancement of accuracy in a recognition memory task and familiarity ratings for happy faces, but 
not for neutral or angry faces. In contrast, Savaskan et al. [2008] administered a single dose of 
oxytocin to volunteers to test post-learning phase oxytocin effects on recognition of emotional 
faces. Their main result was that oxytocin improved identity recognition memory and reduced the 
false alarm rate selectively for faces with a neutral expression or an angry expression, although this 
effect was absent for happy faces. Interestingly, in a study by Di Simplicio et el. [2009], it was 
found that the promnesic effects of oxytocin on emotional material was also found for the memory 
recall of words with positive valence. 
Administering oxytocin during encoding, Rimmele et al. [2009] compared the effects of 
oxytocin on the recognition of emotional faces (i.e. social stimuli) and non-social pictures, showing 
an improvement of accuracy selectively for emotional faces regardless the gender and the valence. 
In a study by Striepens et al. [2012], participants were scanned using functional MRI (fMRI), 
during the encoding of aversive and neutral picture stimuli selected from the International Affective 
Picture System [Bradley and Lang 2007] after receiving either oxytocin or a placebo. Twenty-four 
hours later, on an incidental free recall task, the authors observed an increase of accuracy for 
aversive stimuli related to left insula activations and increased functional coupling between the left 
amygdala, left anterior insula, and left inferior frontal gyrus. 
A unique study that revealed gender differences in the effect of oxytocin in memory tasks 
was published by Herzmann at al. [2013], in which event-related potentials (ERPs) were recorded 
during the learning and recognition phase, while investigating neural correlations of oxytocin’s 
responses to memory encoding and retrieval of own and other-race emotional faces. Exogenous 
intranasal oxytocin increased the accuracy of familiarity judgments in both gender groups and 
neural correlations for this effect in ERPs related to memory encoding and retrieval were observed. 
In contrast, an impairment of recollection judgments was found selectively for male participants.  
Weigand et al. [2013] investigated the influence of a single administration of oxytocin 
before the encoding phase of two doses of oxytocin before encoding and before the retrieval phase 
on recognition memory for neutral, positive and negative social scenes taken from the International 
Affective Picture System [Bradley and Lang 2007]. This study showed that only the administration 
of repeated assumptions of oxytocin significantly improved memory accuracy for negative social 
stimuli. 
In Cardoso and Collaborators [2014], participants completed the Autobiographical Memory 
Test [Williams and Broadbent 1986] after the assumption of 24 or 48 IU of oxytocin. They found 
that only the 24 IU dose increased the number of specific personal memories recalled. These in turn 
promoted the recall of social affiliation memories that were rated more positively. 
Finally, two studies applied an associative memory task that included either emotional 
(smiling and angry faces) or non-emotional (green and red lights) feedback [Hu et al. 2015; 
Hurlemann et al. 2010]. Subjects’ learning performance improved when emotional rather than non-
emotional feedback was provided [Hu et al. 2015; Hurlemann et al. 2010]. fMRI data showed that 
during the response phase, oxytocin selectively increased activity in the amygdala, hippocampus, 
para-hippocampal gyrus and putamen and functional connectivity between the amygdala and insula 
and caudate [Hu et al. 2015]. In summary, studies on intranasal oxytocin effects on long-term 
memory performance using emotional stimuli found an improvement in memory, while no studies 
showed any worsening of memory performance. 
 
DISCUSSION 
In this review, we have summarized the heterogeneous literature reporting intranasal 
oxytocin changes for long-term memory performance on healthy human subjects. The literature 
showed contradictory results and research designs of studies which varied widely in the 
methodologies used (memory and learning paradigms), therefore producing variable outcomes.  The 
studies included here were difficult to compare due to limited oxytocin dosage range, single versus 
repeated administrations and stimulation protocols administered at different timings. Furthermore, a 
large variability of long-term episodic memory measurements was also found. These included 
verbal episodic memory paradigms (i.e., word-learning tasks), non-verbal memory tasks (i.e., facial 
or picture recognition), autobiographical memory test and associative memory task. Moreover, 
mainly male participants were recruited, limiting the interpretation of our findings to a male-
predominant population. Interestingly, one study did show a gender difference in oxytocin response 
on memory abilities [Herzmann et al. 2013], in line with previous research, demonstrating that 
oxytocin affects social cognition aspects do differ for males and females [Domes et al. 2007a; 
Domes et al. 2007b; Domes et al. 2010; Macdonald and Macdonald 2010; Marsh et al. 2010].  
Overall, certain studies demonstrated induced worsening of episodic memory, others 
showed no effect at all on memory, while other research found an improvement of memory 
depending on the type of task used. We found that the common distinction between memory for 
social and non-social stimuli was not completely satisfactory to explain the inconsistent findings of 
these study results. We therefore suggest a preliminary distinction between non-emotional or 
emotional material administered, indicating that while an oxytocin amnestic effect or no effect can 
be found for non-emotional stimuli (verbal, non-verbal, social or non-social) an oxytocin promnesic 
effect was detected systematically for emotional stimuli. 
Interestingly, in a recent study by Feifel et al. [2012] investigating the effects of three weeks 
of daily intranasal administrations of oxytocin in patients with schizophrenia, a beneficial effect on 
long-term verbal memory for non-emotional stimuli was reported. Previous studies found that the 
differential effects of oxytocin may depend on individual characteristics, showing that they may be 
more pronounced in subjects with impaired cognitive abilities, emotion disregulation and with 
higher score of alexithymia [Luminet et al. 2011; Quirin et al. 2014; Weigand et al. 2013]. 
Moreover, nasal sprays are limited in terms of controlling dosing and absorption and consequently 
of drug response [Chini et al. 2014; Guastella and MacLeod 2012]. 
Only one study, using a non-emotional facial stimuli, found any improvement of memory 
performance, i.e., decreased own-race bias [Blandon-Gitlin et al. 2014]. As the authors suggest, we 
might consider that this type of material which did not consider any facial expression, cannot be 
considered exactly non-emotional. This is because emotions may play an important role when the 
participant has to recognize other race faces, as demonstrated in the functional MRI study by 
Cunningham, in which amygdala activity increased more in response to black compared to white 
faces [Cunningham et al. 2004].  
Regarding emotional stimuli, a general improvement of memory performance was detected, 
provoking an improvement of overall accuracy or reduction of certain types of errors or specific 
biases. Oxytocin did enhance memory performance for emotional face expressions, pictures and 
words when administered before the study phase of a long-term memory experiment. It  also 
enhanced memory performance  when administered after the study phase, suggesting that oxytocin 
might not enhance only encoding but also consolidation processes.  
It remains unclear whether the effects of oxytocin spray could have been more specific to 
limited types of expressions (e.g., happy, angry) or to specific valence categories (positive vs. 
negative). Furthermore, it is worth noting that it is difficult to distinguish whether improvements of 
memory performance for emotional tasks are directly related to a memory process enhancement or 
are due to a primary improvement of emotion recognition abilities observed in some research. This 
may increase the salience of material and decrease the cognitive load of the learning process 
[Macdonald and Macdonald 2010]. 
To sum up, oxytocin’s effects on memory can be summarized into a complex picture where 
facilitation or interference effects are dependent on the phase and dose of peptide administration 
(pre- vs. post-memory encoding) and the nature of the stimuli used (emotional vs. non-emotional). 
Although we have identified a link between memory performance and oxytocin in humans, 
conclusions that can be drawn are only tentative and need to be explored further. Oxytocin is 
intricately involved in a broad array of neuropsychiatric functions and it is a new pharmacological 
target for many trials on psychiatric disorders [Cochran et al. 2013].  
We believe that in light of these considerations, clinical trials on patient populations using 
repeated administrations of exogenous intranasal oxytocin, should investigate all the possible 
amnestic and promnesic effects of the neuropeptide. Several studies have shown that long-term 
human memories are influenced by the emotion experienced during learning [Buchanan 2007; 
Phelps 2004]. Further studies need to elucidate oxytocin’s effects on memory describing the effects 
as a function of emotional salience of the learning material and the underlying neural mechanisms. 
In particular, more information is needed to determine the mechanisms of the oxytocin peptide on 
learning and memory processes in order to assess whether oxytocin has any direct effect on the 
synaptic plasticity involved in long-term potentiation and/or long-term depression of synaptic 
transmission or on other neuromodulators. 
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